| PET-CT in clinical oncology. | |
| | |
MedLine Citation:
|
PMID: 17720652 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Anatomic imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) have been used for many years in clinical oncology. The emergence of positron emission tomography (PET) more than a decade ago was a major breakthrough in the early diagnosis of malignant lesions, as it was based on tumour metabolism and not on anatomy. The merger of both techniques into one thanks to PET-CT cameras has made this technology the most important tool in the management of cancer patients. PET/CT with 18F-FDG is increasingly being used for staging, restaging and treatment monitoring for cancer patients with different types of tumours (lung, breast, colorectal, lymphoma, melanoma, head and neck etc.). At many institutions, PET/CT has replaced separately acquired PET and CT examinations for many oncologic indications. This replacement has occurred despite the fact that only a relatively small number of well designed prospective studies have verified imaging findings against the gold standard of histopathologic tissue evaluation. However, a large number of studies have used acceptable reference standards, such as pathology, imaging and other clinical follow-up findings, for validating PET/CT findings. The impact on the management of patients and the benefits from the information obtained from this anatomo-metabolic procedure justify the term "clinical oncology based on PET-CT" as a new concept to be applied in clinical practice. |
| | |
Authors:
|
A Maldonado; F J González-Alenda; M Alonso; J M Sierra |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico Volume: 9 ISSN: 1699-048X ISO Abbreviation: - Publication Date: 2007 Aug |
Date Detail:
|
Created Date: 2007-08-27 Completed Date: 2008-01-07 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101247119 Medline TA: Clin Transl Oncol Country: Spain |
Other Details:
|
Languages: eng Pagination: 494-505 Citation Subset: IM |
Affiliation:
|
Centro PET Recoletas La Milagrosa, Madrid, Spain. antonio.maldonado@gruporecoletas.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Breast Neoplasms
/
radiography,
radionuclide imaging Head and Neck Neoplasms / radiography, radionuclide imaging Humans Lung Neoplasms / radiography, radionuclide imaging Neoplasm Staging Neoplasms / diagnosis*, radiography, radionuclide imaging Positron-Emission Tomography* Thyroid Neoplasms / radiography, radionuclide imaging Tomography, X-Ray Computed* Urogenital Neoplasms / radiography, radionuclide imaging |
| Comments/Corrections | |
Comment In:
|
Clin Transl Oncol. 2007 Aug;9(8):473-4
[PMID:
17720648
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: mTOR signalling in human cancer.
Next Document: Toxicity associated to radiotherapy treatment in lung cancer patients.